Your browser doesn't support javascript.
loading
Aortic cusp extension valvuloplasty for rheumatic aortic valve disease: midterm results.
Grinda, Jean-Michel; Latremouille, Christian; Berrebi, Alain J; Zegdi, Rachid; Chauvaud, Sylvain; Carpentier, Alain F; Fabiani, Jean-Noel; Deloche, Alain.
Afiliación
  • Grinda JM; Department of Cardiac Surgery, Hôpital Européen Georges Pompidou, Paris University, France. jean-michel.grinda@egp.ap-hop-paris.fr
Ann Thorac Surg ; 74(2): 438-43, 2002 Aug.
Article en En | MEDLINE | ID: mdl-12173826
BACKGROUND: The surgical management of rheumatic aortic insufficiency in the young remains problematic owing to the drawbacks of prosthetic valve replacement at this age. In young foreign patients, for whom long-term anticoagulation therapy is unavailable, we have used a glutaraldehyde preserved autologous pericardium cusp extension technique to repair rheumatic aortic valve insufficiencies resulting from cusp retractions. METHODS: From September 1992 to December 2000, 89 consecutive patients with a mean age of 16 +/- 5 years underwent triple pericardial aortic cusp extension valvuloplasty. Eighty patients had pure aortic insufficiency, 9 had mixed aortic disease. Twenty-nine patients (33%) had isolated aortic valve disease and 60 patients (69%) had combined aortic and mitral valve disease with significant tricuspid valve disease in 21 (24%). Aortic repair consisted of free edge aortic cusp extension using three rectangular strips of glutaraldehyde stabilized autologous pericardium. Twenty-nine patients (33%) underwent an isolated aortic repair, 39 patients (44%) underwent combined aortic and mitral procedures (34 mitral repairs, 3 mitral homografts, and 2 prosthesis replacements), and 21 patients (23%) underwent a triple valve repair. RESULTS: The hospital mortality was 2.2%. Primary failure of the aortic repair requiring immediate reoperation occurred in 2 patients. During follow-up (mean of 62 +/- 22 months) 1 patient died and 7 underwent redo valvular surgery. At 5 years the actuarial survival rate was 96.4%, and 92.1% of the patients were free from redo valvular surgery. At 7 years 90% of the patients were free from valve-related complications. Among the 76 patients free from redo valvular surgery at follow-up, 6 had deterioration of the repair resulting in grade II aortic and mitral insufficiencies. CONCLUSIONS: Our midterm results of glutaraldehyde stabilized autologous pericardial aortic cusp extension are encouraging and suggest that this technique should be considered as a viable alternative palliative procedure in a young rheumatic population, allowing for growth of the annulus and delaying to a less critical period the need for the lifelong anticoagulation therapy required for a prosthetic mechanical valve.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Insuficiencia de la Válvula Aórtica / Cardiopatía Reumática / Bioprótesis / Prótesis Valvulares Cardíacas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Ann Thorac Surg Año: 2002 Tipo del documento: Article País de afiliación: Francia
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Insuficiencia de la Válvula Aórtica / Cardiopatía Reumática / Bioprótesis / Prótesis Valvulares Cardíacas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Ann Thorac Surg Año: 2002 Tipo del documento: Article País de afiliación: Francia